José Alves
Research Subjects
Research Interests
José Alves has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Angélica Ramos
Serviço de Patologia Clínica, Centro Hospitalar Universitário de São João, Porto, Portugal
1 shared publication - Cristiana Carpinteiro
LoF—Intelligent Lab on Fiber, Limited, Oxford OX1 2EW, UK
1 shared publication - David Andrew Clifton
University of Oxford
1 shared publication - Filipe Marques
LoF—Intelligent Lab on Fiber, Limited, Oxford OX1 2EW, UK
1 shared publication - Joana S. Paiva
LoF—Intelligent Lab on Fiber, Limited, Oxford OX1 2EW, UK
1 shared publication - João Tiago Guimarães
Faculdade de Medicina, Universidade Do Porto , Porto , Portugal
1 shared publication
Latest Publications
- Open Access
- 21 July 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (8) , 1309
Forecasting COVID-19 Severity by Intelligent Optical Fingerprinting of Blood Samples
Forecasting COVID-19 disease severity is key to supporting clinical decision making and assisting resource allocation, particularly in intensive care units (ICUs). Here, we investigated the utility of time- and frequency-related features of the backscattered signal of serum patient samples to predict COVID-19 disease severity immediately after diagnosis. ICU admission was the primary outcome used to define disease severity. We developed a stacking ensemble machine learning model including the backscattered signal features (optical fingerprint), patient comorbidities, and age (AUROC = 0.80), which significantly outperformed the predictive value of clinical and laboratory variables available at hospital admission (AUROC = 0.71). The information derived from patient optical fingerprints was not strongly correlated with any clinical/laboratory variable, suggesting that optical fingerprinting brings unique information for COVID-19 severity risk assessment. Optical fingerprinting is a label-free, real-time, and low-cost technology that can be easily integrated as a front-line tool to facilitate the triage and clinical management of COVID-19 patients.
- 21 July 2021
- Published by MDPI AG in Diagnostics
- Vol. 11 (8) , 1309
Open AccessForecasting COVID-19 Severity by Intelligent Optical Fingerprinting of Blood Samples
Forecasting COVID-19 disease severity is key to supporting clinical decision making and assisting resource allocation, particularly in intensive care units (ICUs). Here, we investigated the utility of time- and frequency-related features of the backscattered signal of serum patient samples to predict COVID-19 disease severity immediately after diagnosis. ICU admission was the primary outcome used to define disease severity. We developed a stacking ensemble machine learning model including the backscattered signal features (optical fingerprint), patient comorbidities, and age (AUROC = 0.80), which significantly outperformed the predictive value of clinical and laboratory variables available at hospital admission (AUROC = 0.71). The information derived from patient optical fingerprints was not strongly correlated with any clinical/laboratory variable, suggesting that optical fingerprinting brings unique information for COVID-19 severity risk assessment. Optical fingerprinting is a label-free, real-time, and low-cost technology that can be easily integrated as a front-line tool to facilitate the triage and clinical management of COVID-19 patients.